PharMerica Inactive 10-Q2011 Q3 Quarterly report

Filed: 3 Nov 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Bad

New words: adjournment, Advance, affiliate, affiliated, al, apparent, aproxy, ASC, attention, authoritative, avoid, beneficial, Chancery, chosen, Circuit, commence, commenced, Commonwealth, confidential, Confidentiality, consuming, declaratory, deemed, defend, Defense, DGCL, diligence, Dismissal, dispending, disrupting, disruptive, distraction, diversion, Division, draft, Drummond, duration, effort, enjoining, excessive, exempt, expenditure, explained, FASB, FBO, fiduciary, finite, Frank, FTC, hire, HSR, Hugh, illusory, impede, imposing, inadequate, inapplicable, injunctive, interfere, Investor, Joint, Junior, Justice, Kentucky, lack, lawsuit, long, Louisiana, Mellon, mentioned, merit, Municipal, narrowly, nominate, opportunistic, opportunistically, outlined, par, payout, penalty, perception, permanent, Philadelphia, Police, posted, power, PPLU, preceding, privileged, produce, promptly, public, purportedly, qualitative, relief, reversed, seller, shareholder, simplify, slate, solicitationto, speculation, standalone, styled, tailored, takeover, talent, thereon, thereunder, Trust, Trustee, unanimously, uncertainty, undermine, Union, unreasonable, view, vigorously, violated, write

Removed: agreed, announced, applied, AWP, benchmark, billion, Blue, Book, brought, centralized, Chain, collusion, complaint, complying, content, DataBank, discontinue, discoverable, discrete, economy, exposure, factor, field, FMAP, force, funding, HHS, Independent, independently, markup, neutral, neutrality, package, pension, preponderance, publishing, reference, refusal, refused, reimbursing, remain, repository, stand, stimulate, unwilling, WAC

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PharMerica similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PharMerica Corporation (the “Corporation”) on Form 10-Q for the quarter ended September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael J. Culotta, Executive Vice President and Chief Financial Officer of the Corporation, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

/S/ MICHAEL J. CULOTTA

Michael J. Culotta

Executive Vice President and Chief

Financial Officer

November 3, 2011